Clinical and investigational considerations for the use of IGIV therapy
Author:
- 15 August 2005
- journal article
- case report
- Published by Oxford University Press (OUP) in American Journal of Health-System Pharmacy
- Vol. 62 (16_Supplem) , S12-S18
Abstract
Purpose. Clinical uses of immunoglobulin intravenous (IGIV) therapy for a number of autoimmune and inflammatory diseases are discussed, as well as the probable mechanisms by which IGIV exerts its immunoregulatory and antiinflammatory actions. Case studies are also presented to examine practical considerations in the selection of IGIV products for patients at risk for adverse events.Keywords
This publication has 32 references indexed in Scilit:
- Immunomodulation of Autoimmune and Inflammatory Diseases with Intravenous Immune GlobulinNew England Journal of Medicine, 2001
- The Effect of Two Different Dosages of Intravenous Immunoglobulin on the Incidence of Recurrent Infections in Patients with Primary HypogammaglobulinemiaAnnals of Internal Medicine, 2001
- Intravenous immunoglobulin in the treatment of autoimmune neuromuscular diseases: Present status and practical therapeutic guidelinesMuscle & Nerve, 1999
- Common Variable Immunodeficiency: Clinical and Immunological Features of 248 PatientsClinical Immunology, 1999
- Immunological factors and risk of infection in plateau phase myeloma.Journal of Clinical Pathology, 1995
- Hypogammaglobulinaemia in Low Grade B Cell Tumours; Significance and TherapyImmunological Investigations, 1991
- Immunomodulatory and Antimicrobial Efficacy of Intravenous Immunoglobulin in Bone Marrow TransplantationNew England Journal of Medicine, 1990
- Increased susceptibility to mycoplasma infection in patients with hypogammaglobulinemiaThe American Journal of Medicine, 1986
- Chronic rotavirus infection in immunodeficiencyThe Journal of Pediatrics, 1980
- Giardiasis with Malabsorption in X-Linked AgammaglobulinemiaNew England Journal of Medicine, 1972